Emi Yamamoto

Carna Biosciences, Inc.

Carna Biosciences, a biotechnology company focusing on kinases as the important targets for the development of drugs to treat a variety of diseases, including cancer, inflammation, and neurological disorders, offers a wide range of kinase protein products all developed and manufactured in-house and assay services with extensive kinase targets for your research and development. Our biochemical assay services are boast of delivering highly reproducible quality data by employing only our in-house kinases which have passed our stringent QC and conducting experiments under the thoroughly managed assay system by skilled hands. Our cell-based assays which investigate your compounds' binding activities generate reliable data utilizing the well-established Promega's NanoBRET™ technology. In addition to these kinase products and services, our rich experiences, deep knowledge, and know-how in drug discovery targeting kinases will give you unparalleled support which surely helps accelerate your drug discovery. If you are engaged in kinase inhibitor research and development, Carna Biosciences will be your best support partner.